Big business magazine picks McKesson CEO's brain

Still best known as a massive mover of pharmaceuticals, McKesson has become one of the largest health-tech vendors as well—and one of the most formidable American companies in any industry.

Calling McKesson “the healthcare tech giant you've probably never heard of,” Fortune points out that it’s even surpassed such high-profile corporations as AT&T, Bank of America and Walt Disney.

The magazine interviewed McKesson CEO John Hammergren, asking how healthcare technology can help save money as well as lives.

Today’s healthcare providers “need to develop a care plan that makes sense based on individual characteristics of the patient,” Hammergren says in the Q&A article.

McKesson’s customers, for example, need data “that is actionable, that is accurate and that is easy to use.”

Deploying such data “will be paramount to any kind of adoption of personalized medicine,” says Hammergren. “I just don’t think the providers are going to have the time for several hours’ worth of research for each patient they interact with. I think the industry is going to have to automate that.”

Click here to read the whole thing. 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.